Disappointing Quarterly Results Hinder The Chart Prospects Of Orexigen Therapeutics, Inc. (NASDAQ:OREX)
[[tagnumber 0]][[tagnumber 1]]The last twelve months have brought about quite a few developments for Orexigen Therapeutics, Inc. (NASDAQ:OREX), a biotech focused on the treatment of obesity and chronic weight management. During that time, the...